Please assess the completion status of the following clinical trial:

Trial Title: Ability of Pupillometry to Reduce Sufentanil Consumption in Planned Cardiac Surgery: Randomized, Controlled, Single-center Clinical Superiority Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Person who has given written consent~* Adult patient~* Patient undergoing coronary artery bypass surgery with CEC, with or without valve surgery, by sternotomy.~* ASA \<4.~Exclusion Criteria:~* Person not affiliated to the national health insurance system~* Person subject to legal protection (curatorship, guardianship)~* Person who has been deemed mentally incompetent~* Pregnant, parturient or breastfeeding woman~* Adult unable or unwilling to provide consent~* Patient with preoperative cognitive dysfunction (MMS \<13) (APPENDIX 6),~* Patient with morphine intolerance,~* Patient on long-term opioid treatment,~* Emergency surgery,~* Eye disease, corneal injury, or wearing contact lenses, a neurological disease that can influence the pupillary reflex,~* Refusal to participate

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Standard group (Type: OTHER): None
- Pupillometry group (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).